Company Filing History:
1 out of 26 
1 out of 5 Years Active: 2017-2019
Title: The Innovations of Daniel W Bougie
Introduction
Daniel W Bougie is an accomplished inventor based in Germantown, Wisconsin. He has made significant contributions to the field of medical diagnostics, particularly in the detection of platelet-activating antibodies. With a total of two patents to his name, Bougie's work has the potential to improve patient outcomes in cases of heparin-induced thrombocytopenia.
Latest Patents
Bougie's latest patents focus on methods for detecting platelet activation in patients suspected of having heparin-induced thrombocytopenia (HIT). The first patent outlines a method that involves obtaining a blood sample from a patient, incubating platelet factor 4 (PF4) with a sample of platelets, and measuring the extent of platelet activation. An increase in platelet activation compared to normal blood samples indicates the presence of HIT. The second patent presents a similar method, reinforcing the importance of accurate detection in clinical settings.
Career Highlights
Throughout his career, Bougie has worked with notable organizations such as the BloodCenter Research Foundation and the Versiti Blood Research Institute Foundation, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Bougie's notable coworkers include Richard H Aster and Curtis Gerald Jones. Their collective expertise has likely enhanced the quality and impact of the research conducted in their respective fields.
Conclusion
Daniel W Bougie's innovative methods for detecting platelet activation represent a significant advancement in medical diagnostics. His contributions have the potential to greatly benefit patients suffering from heparin-induced thrombocytopenia.